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T-CELL LEUKAEMIA-LYMPHOMA VIRUS AND
HETEROGENEITY OF CHRONIC T-CELL
MALIGNANCIES
SIR,-T-cell chronic lymphocytic leukaemia (T-CCL) is rare in
Europe and the U.S.A., accounting for only 2% of all CLL cases. I
Malignancy of mature T-cells is more frequent in Japan, where this
disorder is usually referred to as adult T-cell leukaemia (ATL).2 2
Serum antibodies against the structural core protein (p24) of a
human C-type leukaemia virus (human T-cell leukaemia-lymphoma
virus or HTLV) have been demonstrated in Japanese patients with
ATL, suggesting a possible viral aetiology. Catovsky et a1. 4 have
reported a series of Black patients of West Indian origin with malig-
nancy of mature T cells virtually indistinguishable from Japanese
ATL and high titre antibodies against HTLV.
Evidence that HTLV-positive T leukaemia is not confined to
Japan prompted us to look for anti-HTLV antibodies in ten patients
from Italy with T-CLL; eight of these patients have been described
elsewhere. ],5,6 All patients were born in Italy and they live (or lived)
in the Rome metropolitan area or in Padua. Slight hypercalcaemia (a
feature of ATL) was observed in patient K while under chemo-
therapy. Nuclear convolutions, but not pleomorphism,2 were noted
in cells from patients J and K who had skin infiltration. Cells from
patients G, H, J, and K displayed the immunological pattern
(T3+,T4+,T8-) recorded by Japanese workers for adult T-cell
leukaemia. 7
Coded serum samples from these ten patients were screened3 and
none possessed antibodies to HTLV. One additional patient, from
Maryland, U.S.A., with a disease clinically and immunologically
indistinguishable from that of the Italian patients was also found to
lack anti-HTLV serum antibodies.
Lymphoproliferative disorders of mature T cells represent a small
but heterogeneous group of diseases. T-CLL from Europe or the
U.S.A. is rare and not yet well defined. Patients with T-CLL some-
times have peripheral and bone marrow lymphocytosis as their main
clinical manifestation and a favourable and chronic course even
without treatment. Its status as a malignant condition has
sometimes been questioned.6,9,1O On the contrary, adult T-cell
leukaemia, which is a more common condition, at least in Japan and
the West Indies, is better characterised. Several clinical and
morphological findings are present in these patients,2 the disease
behaving as a severe and aggressive malignancy resistant to anti-
leukaemic agents. Four of the patients observed by us shared some
features with adult T-cell leukaemia patients (skin involvement,
nuclear convolutions but not pleomorphism, and/or the presence of
T4 antigen on their proliferating cells). These patients also
presented with a more aggressive disease and, unlike other T-CLL
patients, early treatment was needed in three of them. Yet, the lack
of anti-HTLV antibodies in sera from these patients is helpful in
distinguishing between these more severe cases of European
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SUMMARY OF CLINICAL AND IMMUNOLOGICAL DATA OF
T-CLL PATIENTS
T-CLL and true cases of adult T-cell leukaemia, and is also sug-
gestive for the different nature of the two diseases.
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ADULT T-CELL LEUKAEMIA-LYMPHOMA WITH
UNUSUAL PHENOTYPE
SIR,-Adult T-cell leukaemia-lymphoma is endemic in south-
western Japan 1 and has been reported in six Black patients from the
West Indies living in the U.K.2 Three patients with T-cell
malignancies similar or identical to the cases in Japan have been
reported from the north-western part of the United States. We
wish to report another patient from the mid-western United States
with T-cell leukaemia-lymphoma cytologically indistinguishable
from the previously published cases but whose neoplastic leukaemic
cells had a phenotype not previously reported.
A 42-year-old White man presented with generalised
lymphadenopathy, splenomegaly, a right-sided pleural effusion, no
skin lesions, and a white blood cell count (WCC) of 95 x 109/1. 98%
of the white blood cells were pleomorphic lymphocytes with
pronounced nuclear lobulations, some nuclei having a mulberry-
like appearance (fig. 1). The lymphocytes ranged from small
mature-appearing cells with aggregated chromatin to larger blast-
like cells with prominent large nucleoli. These cytological features
were confirmed ultrastructurally (fig. 2). Most of the cells had
diffuse, punctate acid phosphatase activity. Bone marrow biopsy
revealed almost complete replacement by neoplastic lymphocytes.
Flow cytometric analysis (’EPICS V’; Coulter Electronics, Inc.) of
lymphocytes from both peripheral blood and pleural fluid revealed
that the cell surface phenotypes of 97% of the cells were Tl + (pan
T-cell), T3+ (mature T-cell), T4+ (helper/inducer T-cell), and
T8+ (suppressor/cytoxic T-cell). All other monoclonal antibody
probes tested were negative, including TIO, T9, T6, la, J5
(CALLA), Leu 7, Bl, B2, and all surface immunoglobulin heavy
1. Uchiyama T, Yodoi J, Sagawa K. Takatsuki K, Uchino H Adult T cell leukemia:
Clinical and hematologic features of 16 cases. Blood 1977; 50: 481-91.
2. Catovsky D, Rose M, Goolden AWG, et al. Adult T-cell lymphoma-leukaemia in
Blacks from the West Indies Lancet 1982; i: 639-43.
3. Kadin ME, Kamoun M. Nonendemic adult 1-cell leukemia/lymphoma. Hum Pathol
1982; 13: 691-93
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Fig. 1-Peripheral blood showing lymphocytes with nuclear
convolutions.
Fig. 2-Electron micrograph showing irregular nuclei of
lymphocytes.
(Lead and uranyl acetate stain; x about 4000.)
and light chains. The cells also lacked TdT by immunofluorescence
assay. The patient was treated with vincristine, prednisone, and
intrathecal methotrexate; the white blood cell count fell but then
rose to 140 x 109/1. More aggressive therapy (vincristine,
doxorubicin, and prednisone) resulted in a moderate but transient
drop of the white blood cell count. The patient died 22 days after the
diagnosis of his illness.
Cytologically, the patient’s leukaemic cells were
indistinguishable from those in previously reported cases of adult
T-cell leukaemia-lymphoma. 1-3 Although the neoplastic cells had a
mature phenotype and were TdT negative (a characteristic of other
reported cases of this disease) the reaction with both T4 and T8
monoclonal antibodies in the absence of T6 and T10 positivity has
not been previously described. The neoplastic cells in most
previously reported cases have had a helper/inducer phenotype
(T4+, T8-). Nor did the patient have hypercalcaemia, which was
found in some of the cases reported from Japan and in most of the
cases reported by Catovsky et a1. 2 Also, the patient’s plasma did not
have antibodies against disrupted human C-type leukaemia virus
(human T-cell leukaemia-lymphoma virus, HTLV), which has been
reported in many cases from Japan and in all cases from the West
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EFFECT OF CYCLOSPORIN ON
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
SIR,-To explain the renal side-effects encountered during
immunosuppressive therapy with cyclosporin 1,2 an antidiuretic
hormone (ADH) like activity has been proposed,3 although this has
never been proved by laboratory data. In mice and rats we observed
a significant increase in plasma corticosterone levels after single or
repeated daily oral administration.4 This increase was seen at high
doses only and has never been confirmed in patients.
Changes in the urinary Na+/K+ ratio of animals used in toxicity
studies suggested a possible influence of cyclosporin on the renin-
angiotensin-aldosterone system (RAAS). Further studies, in beagle
dogs, pointed to stimulation of the RAAS, as shown by increased
plasma renin activity (PRA) and decreased urinary Na+/K+ ratio
(table). Similar data were obtained in rats, especially in the
EFFECTS OF CYCLOSPORIN A ON PRA AND URINARY
SODIUM/POTASSIUM RATIO IN MALE BEAGLE DOGS AND MALE
SPONTANEOUSLY HYPERTENSIVE RATS
genetically hypertension-prone rat, again indicating profound
stimulation of the RAAS (table). Adrenalectomy abolished the
aldosterone-induced effects on urinary electrolytes (data not
shown). The systolic arterial blood pressure and heart rate were,
however, slightly raised in both adrenalectomised and intact rats.
These data could explain the increased diastolic blood pressure seen
in young patients given cyclosporin for bone marrow transplants. 5
Stimulation of renin release and/or production as well as
subsequent release of angiotensin 11 could be responsible for the
hypertension. In addition, altered renal haemodynamics might
result in hypoxia of the deeper nephrons causing tubular damage. In
this situation prednisone, as reported by Durrant et al., would have
a further detrimental effect on blood pressure and tubular function.
If this stimulatory effect of cyclosporin on the RAAS does occur in
man also, drugs with vasodilatory activity might prevent renin
release and/or adverse effects on the kidney.
Another mechanism has been suggested for the capillary
glomerular thrombosis seen in a few patients on cyclosporin, in
particular after bone marrow transplantation. Experiments
suggest that a poorly defined plasma factor (PSF), which stimulates
prostacyclin synthesis, is reduced in the plasma of cyclosporin-
treated rabbits (Neild GH, Rocchi G, Imberti L, et al.
Unpublished).
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